Haptoglobin's (Hp) 1-1, 2-1, 	Haptoglobin's (Hp) 2-2 phenotypes	preeclampsia risk	17826	18023	Hp phenotype was not significantly associated with the risk of the primary outcome, preeclampsia, severe preeclampsia, or early onset preeclampsia in white/other, Hispanic or black women (Table 2).
daily doses of 400 IU of vitamin E and 1000 mg of vitamin C from 9-16 weeks gestation until delivery.	placebo from 9-16 weeks gestation until delivery.	risk of the primary outcome or preeclampsia	1676	1789	Vitamin supplementation did not reduce the risk of the primary outcome or preeclampsia in women of any phenotype.
Haptoglobin's (Hp) 1-1, 2-1, 	Haptoglobin's (Hp) 2-2 phenotypes	preeclampsia risk	1921	2079	Hp phenotype does not influence preeclampsia risk, or identify a subset of women who may benefit from vitamin C and E supplementation to prevent preeclampsia.
daily doses of 400 IU of vitamin E and 1000 mg of vitamin C from 9-16 weeks gestation until delivery.	placebo from 9-16 weeks gestation until delivery.	preeclampsia risk in Hispanic Hp 2-2 women.	-1	-1	Hispanic 2-2 women who were not taking prenatal vitamins at randomization had a smaller increase in preeclampsia risk with supplementation than Hispanic 2-2 women who were taking prenatal vitamins at randomization (2.01; 0.80–5.01, p?=?0.14 vs. 7.83; 2.01–30.53, p<0.01, Table 4).
